12 completed, 3 unknown, 2 not yet recruiting, 1 recruiting. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Completed 12, Unknown 3, Not yet recruiting 2, Recruiting 1 |
Follow Roflumilast: new trials by email Literature Review of Roflumilast trials Research Report on Roflumilast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation | Phase 4 | Not yet recruiting | Sidra Aziz | 70 | 2027-02-01 | 2026-08-31 |
| An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis Roflumilast 0.3% topical cream - Chronic Plaque Psoriasis, Nail Psoriasis | Phase 4 | Recruiting | Modern Research Associates, PLLC | 15 | 2026-09-15 | 2026-10-01 |
| Utilization of a Microdevice for Psoriasis and Atopic Dermatitis In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis | Phase 4 | Not yet recruiting | University of California, San Francisco | 10 | 2026-08-01 | 2026-06-03 |
| Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata Roflumilast, intralesional steroid - Alopecia, Alopecia Areata | Phase 4 | Completed | Cairo University | 50 | 2025-01-12 | 2025-09-15 |
| Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin Roflumilast, Vehicle (Roflumilast 0.3% vehicle cream) - Healthy Skin | Phase 4 | Unknown | Rao Dermatology | 3 | 2024-05-28 | 2024-06-03 |
| Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO) Roflumilast 500 Mcg Oral Tablet, Placebo - Chronic Hand Eczema | Phase 4 | Completed | Jacob Pontoppidan Thyssen | 41 | 2023-09-25 | 2026-08-06 |
| Role of Roflumilast in Ulcerative Colitis Roflumilast 500 MCG Oral Tablet [DALIRESP], amino salicylic acid - Ulcerative Colitis | Phase 4 | Completed | Tanta University | 52 | 2023-02-01 | 2025-01-28 |
| PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome metformin, liraglutide, roflumilast - PCOS, Obesity | Phase 4 | Completed | University Medical Centre Ljubljana | 45 | 2014-03-01 | 2014-07-10 |
| Strategy to Improve Adherence of Roflumilast Roflumilast escalation dosage, Roflumilast conventional dosage - Chronic Obstructive Pulmonary Disease | Phase 4 | Unknown | Asan Medical Center | 80 | 2013-12-01 | 2013-12-23 |
| PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome metformin, metformin and roflumilast - PCOS, Obesity | Phase 4 | Completed | University Medical Centre Ljubljana | 36 | 2013-09-01 | 2014-01-22 |
| Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) Roflumilast, Placebo - Sarcoidosis | Phase 4 | Unknown | University of Cincinnati | 50 | 2013-04-01 | 2015-12-08 |
| The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis Roflumilast, Placebo - COPD, Chronic Bronchitis | Phase 4 | Completed | Johns Hopkins University | 12 | 2013-03-18 | 2017-07-27 |
| Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD Roflumilast - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | University of Pittsburgh | 26 | 2013-02-01 | 2017-08-29 |
| Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily Roflumilast alternated days, Roflumilast 500 mcg per day - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Fundación Pública Andaluza Progreso y Salud | 105 | 2012-07-01 | 2015-07-08 |
| Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD) Roflumilast, Placebo - Chronic Obstructive Pulmonary Disease and Allied Conditions | Phase 4 | Completed | LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology | 80 | 2012-05-01 | 2019-04-12 |
| Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients Roflumilast, Placebo of Roflumilast, Functional Respiratory Imaging - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | FLUIDDA nv | 41 | 2011-12-01 | 2013-09-19 |
| Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Roflumilast, Placebo - COPD, COPD Exacerbation | Phase 4 | Completed | AstraZeneca | 2354 | 2011-09-30 | 2017-04-13 |
| Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) Roflumilast, Placebo - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | AstraZeneca | 1945 | 2011-05-01 | 2016-12-13 |
Pulmonary Disease, Chronic Obstructive (9) · Lung Diseases (2) · Obesity (2) · Alopecia (1) · Alopecia Areata (1) · Bronchiectasis (1) · Bronchitis, Chronic (1) · Colitis, Ulcerative (1) · Dermatitis, Atopic (1) · Dyspnea (1) · Emphysema (1) · Fibrosis (1) · Psoriasis (1) · Respiration Disorders (1) · Sarcoidosis (1)
AstraZeneca (2) · University Medical Centre Ljubljana (2) · Asan Medical Center (1) · Cairo University (1) · FLUIDDA nv (1) · Fundación Pública Andaluza Progreso y Salud (1) · Jacob Pontoppidan Thyssen (1) · Johns Hopkins University (1) · LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology (1) · Modern Research Associates, PLLC (1) · Rao Dermatology (1) · Sidra Aziz (1) · Tanta University (1) · University of California, San Francisco (1) · University of Cincinnati (1)
United States (6) · Spain (3) · Austria (2) · Belgium (2) · Canada (2) · Denmark (2) · Egypt (2) · Italy (2) · Russia (2) · Slovenia (2) · South Korea (2) · Argentina (1) · Australia (1) · Brazil (1) · Chile (1)
Andrej Janez, MD, PhD (2) · Beth Laube, PhD (1) · Gregorio Soto, M.D. (1) · Jessica Bon Field, MD, MS (1) · Lieven Bedert, MD (1) · Nadia Hansel, MD MPH (1) · Otto C Burghuber, M.D. (1) · Raymond Cho, MD, PhD (1) · Robert P Baughman, MD (1)
PMID 29763572, PMID 22791991, PMID 25684586, PMID 26032655, PMID 27585384, PMID 28679611, PMID 29579254, PMID 29797235, PMID 31354255, PMID 32725799, PMID 34744427